Clinica Universidad de Navarra
Also known as: Clinica Universidad de Navarra | Clínica Universidad de Navarra | Clinica Universidad de Navarra and Barcelona Institute of Global Health | Clínica Universidad de Navarra (Pamplona) | Clinica Universidad de Navarra, Universidad de Navarra | Clinica Universitaria de Navarra | Clinica Universitaria, Universidad de Navarra | Complejo Hospitalario de Navarra | Complejo Hospitalario de Navarra (Pamplona, Spain) | Hematology, Clinica Universidad de Navarra (Pamplona-Spain) | Hospital de Navarra | Hospital De Navarra Irunlarrea, Spain | Hospital of Navarra | Liver Unit, Clínica Universidad de Navarra | Liver Unit, Clinica Universidad de Navarra/Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBERehd)/Centro de Investigación Medica Aplicada (CIMA)(Pamplona-Spain) | Liver Unit, Clinica Universidad de Navarra/Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBERehd)(Pamplona-Spain) | Navarra Clinic | Oncology Department. Clinica Universitaria de Navarra | Radiology, Clinica Universidad de Navarra (Pamplona-Spain) | Unidad de Investigacion Clinica. Clinica Universidad Navarra (CUN) | University of Navarra, Pamplona, Spain | University of Navarrra Hospital (Clinica Universitaria)
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2002Last known activity
Feb 1, 2026
Timeline
1960s
- Jun 1, 1962
Clinica Universidad de Navarra— Founded
Drugs by trial phase (126 distinct, 98 trials)
Phase 4 (27 own, 0 via acquisition)
Phase 3 (24 own, 0 via acquisition)
Phase 2 (47 own, 0 via acquisition)
Phase 1 (14 own, 0 via acquisition)
Indications
Studied for
- Acute-On-Chronic Liver Failure
- Anemia
- Anus Neoplasms
- Asthenia
- Asthma
- Atrial Fibrillation
- Bacteremia
- Brain Stem Infarctions
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Catheter-Related Infections
- Colonic Diseases
- Colonic Neoplasms
- Colorectal Neoplasms
- Communicable Diseases
- Coronavirus Infections
- End Stage Liver Disease
- Eye Pain
- Fibrosis
- Glaucoma
- Glioblastoma
- Glioma
- Graft vs Host Disease
- Head and Neck Neoplasms
- Heart Failure
- Hepatic Insufficiency
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Idiopathic Pulmonary Fibrosis
- Infections
- Ischemia
- Klippel-Trenaunay-Weber Syndrome
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukopenia
- Liver Failure
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Multiple Sclerosis
- Multiple Sclerosis, Chronic Progressive
- Multiple Sclerosis, Relapsing-Remitting
- Neoplasm Metastasis
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Ocular Hypertension
- Osteoarthritis
- Osteoarthritis, Knee
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Parkinson Disease
- Peanut Hypersensitivity
- Pneumonia
- Porphyria, Acute Intermittent
- Porphyria, Erythropoietic
- Porphyrias
- Psoriasis
- Pulmonary Fibrosis
- Rectal Neoplasms
- Recurrence
- Reperfusion Injury
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Sclerosis
- Severe Acute Respiratory Syndrome
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Sturge-Weber Syndrome
- Syndrome
- Thrombocytopenia
- Thrombosis
- Triple Negative Breast Neoplasms
- Urticaria
- Vomiting
- Wounds and Injuries
Recent trials (50)
- NCT07284095Lead sponsorN/AFeb 1, 2026
- NCT07165457Lead sponsorN/ASep 4, 2025
- NCT06956807CollaboratorPhase 1Sep 1, 2025
- NCT07045909OfficialPhase 2Jun 30, 2025
- NCT06099119CollaboratorPhase 4Nov 30, 2023
- NCT05849610Study chairPhase 2Nov 30, 2023
- NCT06085976Lead sponsorPhase 2Aug 14, 2023
- NCT05781243CollaboratorPhase 4Jun 19, 2023
- NCT05797792OfficialPhase 3Jun 1, 2023
- NCT05440864CollaboratorPhase 2Jan 31, 2023
- NCT05440864Overall official - principal investigatorPhase 2Jan 31, 2023
- NCT05400811OfficialPhase 3Dec 31, 2022
- NCT05527340OfficialPhase 2Sep 30, 2022
- NCT05527340Study chairPhase 2Sep 30, 2022
- NCT05265650Lead sponsorPhase 1/Phase 2Jun 13, 2022
Details
- Founded
- Pamplona, ES Jun 1, 1962
- Last known activity
- Feb 1, 2026